ABSTRACT
INTRODUCTION
Tobacco use, particularly cigarette smoking, is widely recognized by the medical community and the general public as a major public health problem. Physicians and medical organizations share a public health duty to address this problem. Physicians and their professional organizations must contribute effectively to measures undertaken to deal with cigarette smoking (1) .
Worldwide, cigarrette smoking kills four million people each year and the figure is increasing. In most countries, the worst is yet to come, for by the time present young smokers reach middle or old age there will be about 10 million deaths from tobacco per year. Approximately 500 million individuals alive today can expect to be killed by tobacco; 250 million of these deaths will occur in the middle age (2, 3) .
Cigarette smoking can kill in many different ways. In developed countries as a whole, tobacco is responsible for 24% of all male deaths and 7% of all female deaths. The average loss of life expectancy of smokers is eight years; however, for those who die in middle age , this is as much as 22 years (4).
Physicians play several critical roles in society, such as role models, providers of information, identifiers/modifiers of risky behaviour, lobbyists and researchers. The studies indicate a rate of smoking between 20.5%-42.3% for women, 39.4%-52.8% for men among Turkish physicians (5-10). The present study was designed to elicit information on these physicians' knowledge and attitudes to smoking, as well as their own smoking habits.
The purpose of this study is to describe the prevalence of smoking among the university physicians and to analyze the relationship between ever-smoking experience and various risk factors, including demographic factors, knowledge, attitudes, smoking in family members and close friends.
SUBJECTS AND METHODS
All professors, associate professors, assistant professors, lecturers and research assistants working for the Faculty of Medicine of Meram, University of Selçuk, were included in the study. Of the 500 subjects, 363 (72.6%) completed the anonymous questionnaire of the survey satisfactorily. During this study, the number of the participants decreased as some of them were appointed to other universities, joined the army, were at meetings, or were on academic holiday. All individuals in the sample were asked to respond to a series of questions in a face-to-face interview. Standard questions were used in the classification of smoking status in the United States of America (USA) (11) , questions recommended by Prochaska and colleagues to identify stages of change (12, 13) , and Fagerstrom nicotine dependence test questions (14) were used. The survey comprised four parts. The first part was designed to elicit socio-demographic variables. The second was related to smoking behaviour. The third part was designed to determine a Fagerstrom score for nicotine addiction, and the fourth part was related to smoking behaviour of family and close friends. Statistical analysis included the chisquare test for nominal variables. A significance level of p < 0.05 was used.
RESULTS
The sample included 500 individuals, 363 of whom agreed to be surveyed (72.6% response rate). The mean age was 34.2 ± 9.1 years (median = 30.0 years and min: 23 years; max: 65 years). The rate of ever-smokers was 28.7% (n = 104). The proportions of ever-smokers in females and males were 13.4% (n = 15) and 35.6% (n = 89) respectively (p = 0.000). The rate of former smokers was 9.9% (n = 36). The rate of never-smokers was 61.4% (n = 223). The socio-demographic characteristics of the physicians surveyed are presented on Table 1 . bres y 37.5% (9/24) The smoking prevalence among the physician respondents of this study was 13.4% for women and 35.6% for men. The mean age at starting smoking was 21.7 ± 4.9 years (median = 20.0 years and min: 11 years; max: 38 years); ents, spouses and sister and/or brother (p = 0.003) and among close friends (p = 0.000) of the smoker group was higher than the non-smokers (Table 3, 
4).
Using the Fagerstrom scoring, the level of nicotine addiction score was averaged 2.8 ± 2.7 (median = 2.0 and min: 0, max: 9) among all smokers, with 51.9% scoring 0-2 (n = 54), 16.3% scoring 3-4 (17), 13.5% scoring 5 (n = 14), 12.5% scoring 6-7 (n = 13), 5.8% scoring 8-10 (n = 6). There was no significant difference between the average score for males and females (p = 0.033). The Fagerstrom score did not correlate with age.
The quit ratio was 25.7% (36/140) [23.3% (27/116) for men and 37.5% (9/24) for women]. It means that females were 1.6 times more likely to quit than males; 82.1% of smokers consumed less than a pack. When the smokers were classified according to Prochaska and Goldstein's staged changing period model of quitting, 58.7% (n = 61) did not plan to quit (pre-contemplators), 8.7% (n = 9) planned to quit (contemplators), and 32.7% (n = 34) were preparing to quit (preparators). The quitters were classified as: 19.4% (n = 7) were in the trial period (less than six months since quitting) 80.6% (n = 29) were in the maintenance period (more than six months since quitting). The reason for smoking cessation: was 25% (n = 9) health problems, 11.1% (n = 4) social pressure (from family or companionship), 63.9% (n = 23) knowledge of harmful effects of smoking. The differences among weight categories with regard to giving-up smoking and never smoking were not significant (p > 0.05).
DISCUSSION
In this study, the smoking rate among physicians was 13.4% for women and 35.6% for men about half that of the general population in Turkey (females, 24.3%; males, 62.8%) (15) . In previous studies, conducted on physicians between 1991-2000, this rate was between 20.5-42.3% for women, 39.4-52.9% for men (5) (6) (7) (8) (9) (10) . At present, the smoking prevalence among physicians is lower than in the previous reports. The smoking rate among male physicians is higher than that in the USA (females, 3%; males, 10%) (16-18) the United Kingdom (females, 4%; males, 5%) (19) (20) , Australia (females, 1.6%; males, 4.2%) (21) , and New Zealand (5%) (22) , but similar to that in some other developed countries, such as France (females, 24%; males, 33%) (23), Italy (females, 29%; males, 34%) (24), Japan (females, 6.8%; males, 27.1%) (25) and the Netherlands (females, 24%; males, 41%) (26). 79.8% (n = 83) had started before age 25 years. The per cent of the subjects who smoked 31 and more cigarettes/day was 1.9% (n = 2), 21-30 cigarettes/day was 15.4% (n = 16), 11-20 cigarettes/day was 35.6% (n = 37), 10 and fewer cigarettes/day was 47.1% (n = 49). Physicians smoking-related habits were shown in Table 2 . The rate of smoking in the par-
The mean age at initiation of smoking was 21.7 years, with 79.8% of smokers starting to smoke before the age of 25 years. These are consistent with data from similar studies (27) . In Western countries, the age at starting to smoke is between 11 and 15 years. This was found to be unexpectedly lower (29, 30) .
Having close friends and family members who smoked were strong factors for smoking (31, 32) . The risk was highest when the father was a smoker. Parental smoking may cause children to view smoking as an acceptable adult behaviour that is engaged in by those they most admire (31) . Similarly, higher smoking rates were found in the family members of smoking subjects compared to those of never smokers and ex-smokers (p = 0.003). In this study, the rate of smoking in the families and among close friends of the smoker-group was significantly higher than the non-smokers (p = 0.000).
Smoking cessation in females was 1.6 times more than in males. This might be due to differences in motivation and support and to fewer males smoking less than one pack per day. Social pressure is one of the reasons for quitting smoking and is an area that can be used to achieve better results in smoking cessation. Physicians already have a better knowledge of the adverse health effects of smoking. There needs to be more social pressure in public and more institutional policy on smoking. A national action plan against smoking is mandatory (33).
Collection of accurate information on smoking among doctors is important for several reasons. Doctor's tobacco use both reflects and influences their attitudes to tobacco. As well as endangering their own health, doctors who smoke may send a misleading message to their patients and to the public. Doctors who do not smoke are more likely to help their patients to quit. Changes in doctors smoking habits can indicate future trends in the population (11) .
The majority of smokers who quit smoking gain weight. Most will gain fewer than 10 pounds, but there is a broad range of weight gain, with as many as 10 per cent of quitters gaining as much as 30 pounds (34) (35) (36) . However, weight gain that follows smoking cessation is a negligible health threat compared with the risks of continued smoking (37) . In this study, the differences among weight categories with regard to smokers, quitters and never-smoked were not significant (p > 0.05).
In summary, smoking cessation programmes should be introduced among Turkish medical doctors to reduce the number of those who smoke. Also, a continuing education programme should be instituted to instruct doctors about their role in society. Physicians are in a position to lead their country in combating the smoking epidemic and preventing serious morbidity and mortality in the population from smoking. The prevalence of smoking in Turkey is expected to decrease as that in health workers decrease.
